Q4 2021 Holdings
Filed 2022-05-16 | 16 holdings | $3.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc.(COGT) | Common Stock | 19240Q201 | $1.9M | 222,976 | 63.8% |
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $436.5K | 6,875,698 | 14.6% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $138.2K | 8,201,638 | 4.6% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $106.2K | 8,934,902 | 3.5% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $87.0K | 3,209,627 | 2.9% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $62.9K | 5,018,178 | 2.1% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $58.6K | 8,278,876 | 2.0% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $47.2K | 2,232,251 | 1.6% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $44.2K | 2,759,344 | 1.5% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $36.6K | 3,103,879 | 1.2% |
| AvroBio, Inc. | Common Stock | 05455M100 | $17.4K | 4,520,863 | 0.6% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $16.5K | 1,031,160 | 0.6% |
| Magenta Therapeutics, Inc. | Common Stock | 55910K108 | $15.4K | 3,476,536 | 0.5% |
| Gemini Therapeutics, Inc. | Common Stock | 36870G105 | $15.3K | 5,254,365 | 0.5% |
| F-star Therapeutics, Inc. | Common Stock | 30315R107 | $3.0K | 599,524 | 0.1% |
| Viridian Therapeutics, Inc.(VRDN) | Common Stock | 92790C104 | $1.8K | 90,072 | 0.1% |